Cargando…
IR-Surviving NSCLC Cells Exhibit Different Patterns of Molecular and Cellular Reactions Relating to the Multifraction Irradiation Regimen and p53-Family Proteins Expression
SIMPLE SUMMARY: For the first time, we demonstrated that the significant decrease in p63/p73 expression together with the absence of functional p53 could underlie an increase in the fraction of polyploid cells, transformation rates, and the glycolytic NAD(P)H production in multifraction X-ray radiat...
Autores principales: | Alhaddad, Lina, Pustovalova, Margarita, Blokhina, Taisia, Chuprov-Netochin, Roman, Osipov, Andreyan N., Leonov, Sergey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198560/ https://www.ncbi.nlm.nih.gov/pubmed/34071477 http://dx.doi.org/10.3390/cancers13112669 |
Ejemplares similares
-
The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status
por: Pustovalova, Margarita, et al.
Publicado: (2021) -
The p53–53BP1-Related Survival of A549 and H1299 Human Lung Cancer Cells after Multifractionated Radiotherapy Demonstrated Different Response to Additional Acute X-ray Exposure
por: Pustovalova, Margarita, et al.
Publicado: (2020) -
CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status
por: Pustovalova, Margarita, et al.
Publicado: (2022) -
Polyploid/Multinucleated Giant and Slow-Cycling Cancer Cell Enrichment in Response to X-ray Irradiation of Human Glioblastoma Multiforme Cells Differing in Radioresistance and TP53/PTEN Status
por: Alhaddad, Lina, et al.
Publicado: (2023) -
Long-Term Cultured Human Glioblastoma Multiforme Cells Demonstrate Increased Radiosensitivity and Senescence-Associated Secretory Phenotype in Response to Irradiation
por: Alhaddad, Lina, et al.
Publicado: (2023)